Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 639862, 9 pages
http://dx.doi.org/10.1155/2011/639862
Research Article

Selective Th2 Upregulation by Crocus sativus: A Neutraceutical Spice

1Cell Biology (Flowcytometry), Indian Institute of Integrative Medicine, Canal Road, Jammu Tawi 180001, India
2Natural Plant Products Division, Institute of Himalayan Bioresource Technology (CSIR), Palampur 176061, India

Received 19 March 2010; Revised 15 May 2010; Accepted 30 June 2010

Copyright © 2011 Sarang Bani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Cooper, “Complementary and alternative medicine, when rigorous, can be science,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 1, pp. 1–4, 2004. View at Google Scholar
  2. E. L. Cooper, B. Ru, and N. Weng, “Earthworms: sources of antimicrobial and anticancer molecules,” in Complementary and Alternative Approaches to Biomedicine, E. L. Cooper and N. Yamaguchi, Eds., pp. 359–390, Kluwer Academic Publishers, Dodrecht, The Netherlands, 2004. View at Google Scholar
  3. E. L. Cooper, T. M. Hrzenjak, and M. Grdiša, “Alternative sources of fibrinolytic, anticoagulative, antimicrobial and anticancer molecules,” International Journal of Immunopathology and Pharmacology, vol. 17, no. 3, pp. 237–244, 2004. View at Google Scholar · View at Scopus
  4. B. Haefner, “Drugs from the deep: marine natural products as drug candidates,” Drug Discovery Today, vol. 8, no. 12, pp. 536–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. L. Cooper, “Drug discovery, CAM and natural products,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 215–217, 2004. View at Google Scholar · View at Scopus
  6. J.-D. Lee, H.-J. Park, Y. Chae, and S. Lim, “An overview of bee venom acupuncture in the treatment of arthritis,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 79–84, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. É. W. Teixeira, G. Negri, R. M. S. A. Meira, D. Message, and A. Salatino, “Plant origin of green propolis: bee behavior, plant anatomy and chemistry,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 85–92, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. Y. B. Tripathi, B. K. Singh, R. S. Pandey, and M. Kumar, “BHUx: a patent polyherbal formulation to prevent atherosclerosis,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 2, pp. 217–221, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. E. L. Cooper, “eCAM benefits from diversity that derives from CAM,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. T. R. Mosmann and R. L. Coffman, “TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties,” Annual Review of Immunology, vol. 7, pp. 145–173, 1989. View at Google Scholar · View at Scopus
  11. A. Zargari, Medicinal Plants, vol. 4, Tehran University Press, Tehran, Iran, 1990.
  12. H. Hosseinzadeh and H. M. Younesi, “Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice,” BMC Pharmacology, vol. 2, article 7, 2002. View at Publisher · View at Google Scholar
  13. Y. Chen, H. Zhang, X. Tian et al., “Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: a relationship investigation between antioxidant activity and crocin contents,” Food Chemistry, vol. 109, no. 3, pp. 484–492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. D. Kanaris, P. A. Tarantilis, H. A. Tajmir-Riahi, and M. G. Polissiou, “Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties,” Journal of Agricultural and Food Chemistry, vol. 55, no. 3, pp. 970–977, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. L. Sheng, Z. Qian, S. Zheng, and L. Xi, “Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase,” European Journal of Pharmacology, vol. 543, no. 1–3, pp. 116–122, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. Xi, Z. Qian, X. Shen, N. Wen, and Y. Zhang, “Crocetin prevents dexamethasone-induced insulin resistance in rats,” Planta Medica, vol. 71, no. 10, pp. 917–922, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. Mohajeri, G. Mousavi, and Y. Doustar, “Antihyperglycemic and pancreas-protective effects of Crocus sativus L. (Saffron) stigma-ethanolic extract on rats with alloxan-induced diabetes,” Journal of Biological Sciences, vol. 9, no. 4, pp. 302–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. V. K. Dhingra, T. R. Seshadri, and S. K. Mukerjee, “Minor carotenoid glycosides from saffron (Crocus sativus),” Indian Journal of Chemistry, vol. 13, no. 4, pp. 339–341, 1975. View at Google Scholar
  19. Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India, “CPCSEA guidelines for laboratory animal facility,” Indian Journal of Pharmacology, vol. 35, pp. 257–274, 2003. View at Google Scholar
  20. Organization for Economic Cooperation and Development (OECD), “OECD guidelines for testing of chemicals. Guideline 423, acute oraltoxicity—acute toxic class method,” March 1996.
  21. D. S. Nelson and P. Midenhall, “Studies on cytophillic antibodies. The production by mice of macrophage cytophillic antibodies to sheep erthrocytes, relationship to the production of other antibodies and development of delayed type hypersensitivity,” Australian Journal of Experimental Biology & Medical Science, vol. 45, pp. 113–130, 1967. View at Google Scholar · View at Scopus
  22. N. S. Doherty, “Selective effects of immunosuppressive agents against the delayed hypersensitivity response and humoral response to sheep red blood cells in mice,” Agents and Actions, vol. 11, no. 3, pp. 237–242, 1981. View at Google Scholar · View at Scopus
  23. S. Raisuddin, S. I. A. Zaidi, K. P. Sing, and P. K. Ray, “Effect of subchronic aflatoxin exposure on growth and progression of Ehrlich's ascites tumor in mice,” Drug and Chemical Toxicology, vol. 14, no. 1-2, pp. 185–206, 1991. View at Google Scholar · View at Scopus
  24. S. Bani, A. Kaul, B. Khan et al., “Immunosuppressive properties of an ethyl acetate fraction from Euphorbia royleana,” Journal of Ethnopharmacology, vol. 99, no. 2, pp. 185–192, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. Bani, A. Kaul, B. Khan et al., “Suppression of T lymphocyte activity by lupeol isolated from Crataeva religiosa,” Phytotherapy Research, vol. 20, no. 4, pp. 279–287, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. B. Patwardhan and M. Gautam, “Botanical immunodrugs: scope and opportunities,” Drug Discovery Today, vol. 10, no. 7, pp. 495–502, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. F. Plaeger, “Clinical immunology and traditional herbal medicines,” Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 3, pp. 337–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Stephens, S. C. Eisenbarth, and D. D. Chaplin, “T helper type 1 cells in asthma: friend or foe?” Current Opinion in Allergy and Clinical Immunology, vol. 2, no. 1, pp. 31–37, 2002. View at Google Scholar · View at Scopus
  29. A. Oberholzer, C. Oberholzer, and L. L. Moldawer, “Cytokine signaling—regulation of the immune response in normal and critically ill states,” Critical Care Medicine, vol. 28, no. 4, pp. 3–12, 2000. View at Google Scholar · View at Scopus
  30. H. A. Wieland, M. Michaelis, B. J. Kirschbaum, and K. A. Rudolphi, “Osteoarthritis—an untreatable disease?” Nature Reviews Drug Discovery, vol. 4, no. 4, pp. 331–344, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. M. Whelan, J. Whelan, N. Russell, and A. Dalgleish, “Cancer immunotherapy: an embarrassment of riches?” Drug Discovery Today, vol. 8, no. 6, pp. 253–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Descotes, An Introduction to Immunotoxicology, Taylor & Francis, London, UK, 1999.
  33. M. I. Luster, J. H. Dean, and G. A. Boorman, “Cell-mediated immunity and its application in toxicology,” Environmental Health Perspectives, vol. 43, pp. 31–36, 1982. View at Google Scholar · View at Scopus
  34. J. H. Dean, M. L. Padarathsingh, and T. R. Jerrells, “Application of immunocompetence assays for defining immunosuppression,” Annals of the New York Academy of Sciences, vol. 320, pp. 579–590, 1979. View at Google Scholar · View at Scopus
  35. R. Verpoorte, Y. H. Choi, and H. K. Kim, “Ethnopharmacology and systems biology: a perfect holistic match,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 53–56, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. B. Patwardhan, “Ayurveda: the designer medicine. Review of ethnopharmacology and bioprospecting research,” Indian Drugs, vol. 37, no. 5, pp. 213–227, 2000. View at Google Scholar · View at Scopus